Stem cells reveal how illness-linked genetic variation affects neurons

A genetic variation linked to schizophrenia, bipolar disorder and severe depression wreaks havoc on connections among neurons in the developing brain, a team of researchers reports. The study, led by Guo-li Ming, M.D., Ph.D., and Hongjun Song, Ph.D., of the Johns Hopkins University School of Medicine and described online Aug. 17 in the journal Nature, used stem cells generated from people with and without mental illness to observe the effects of a rare and pernicious genetic variation on young brain cells. The results add to evidence that several major mental illnesses have common roots in faulty "wiring" during early brain development.

"This was the next best thing to going back in time to see what happened while a person was in the womb to later cause mental illness," says Ming. "We found the most convincing evidence yet that the answer lies in the synapses that connect brain cells to one another."

Previous evidence for the relationship came from autopsies and from studies suggesting that some genetic variants that affect synapses also increase the chance of mental illness. But those studies could not show a direct cause-and-effect relationship, Ming says.

One difficulty in studying the genetics of common mental illnesses is that they are generally caused by environmental factors in combination with multiple gene variants, any one of which usually could not by itself cause disease. A rare exception is the gene known as disrupted in schizophrenia 1 (DISC1), in which some mutations have a strong effect. Two families have been found in which many members with the DISC1 mutations have mental illness.

To find out how a DISC1 variation with a few deleted DNA "letters" affects the developing brain, the research team collected skin cells from a mother and daughter in one of these families who have neither the variation nor mental illness, as well as the father, who has the variation and severe depression, and another daughter, who carries the variation and has schizophrenia. For comparison, they also collected samples from an unrelated healthy person. Postdoctoral fellow Zhexing Wen, Ph.D., coaxed the skin cells to form five lines of stem cells and to mature into very pure populations of synapse-forming neurons.

After growing the neurons in a dish for six weeks, collaborators at Pennsylvania State University measured their electrical activity and found that neurons with the DISC1 variation had about half the number of synapses as those without the variation. To make sure that the differences were really due to the DISC1 variation and not to other genetic differences, graduate student Ha Nam Nguyen spent two years making targeted genetic changes to three of the stem cell lines.

In one of the cell lines with the variation, he swapped out the DISC1 gene for a healthy version. He also inserted the disease-causing variation into one healthy cell line from a family member, as well as the cell line from the unrelated control. Sure enough, the researchers report, the cells without the variation now grew the normal amount of synapses, while those with the inserted mutation had half as many.

"We had our definitive answer to whether this DISC1 variation is responsible for the reduced synapse growth," Ming says.

To find out how DISC1 acts on synapses, the researchers also compared the activity levels of genes in the healthy neurons to those with the variation. To their surprise, the activities of more than 100 genes were different. "This is the first indication that DISC1 regulates the activity of a large number of genes, many of which are related to synapses," Ming says.

The research team is now looking more closely at other genes that are linked to mental disorders. By better understanding the roots of mental illness, they hope to eventually develop better treatments for it, Ming says.

More here:
Stem cells reveal how illness-linked genetic variation affects neurons

Blood Cells Generate Neurons in Crayfish; Could Have Implications for Treatment of Neurodegenerative Disorders

Contact Information

Available for logged-in reporters only

Newswise A new study by Barbara Beltz, the Allene Lummis Russell Professor of Neuroscience at Wellesley College, and Irene Sderhll of Uppsala University, Sweden, published in the August 11 issue of the journal Developmental Cell, demonstrates that the immune system can produce cells with stem cell properties, using crayfish as a model system. These cells can, in turn, create neurons in the adult animal. The flexibility of immune cells in producing neurons in adult animals raises the possibility of the presence of similar types of plasticity in other animals.

We have been suspicious for some time that the neuronal precursor cells (stem cells) in crayfish were coming from the immune system, Beltz wrote. The paper contains multiple lines of evidence that support this conclusion, in addition to the experiments showing that blood cells transferred from a donor to a recipient animal generate neurons.

Beltz, whose research focuses on the production of new neurons in the adult nervous system, uses the crustacean brain as the model system because the generations of precursor cells are spatially segregated from one another. According to Beltz, this separation is crucial because it allowed the researchers to determine that the first generation precursors do not self-renew. For the Developmental Cell study, the cells of one crayfish were labeled and this animals blood was used for transfusions into another crayfish. They found that the donor blood cells could generate neurons in the recipient.

In many adult organisms, including humans, neurons in some parts of the brain are continually replenished. While this process is critical for ongoing health, dysfunctions in the production of new neurons may also contribute to several neurological diseases, including clinical depression and some neurodegenerative disorders.

Beltz notes, of course, that it is difficult to extrapolate from crayfish to human disease. However, because of existing research suggesting that stem cells harvested from bone marrow also can become neural precursors and generate neurons, she says it is tempting to suggest that the mechanism proposed in crayfish may also be applicable in evolutionarily higher organisms, perhaps even in humans.

Prior studies conducted in both humans and mice and published about a decade ago, showed that bone marrow recipients who had received a transplant from the opposite gender had neurons with the genetic signature of the opposite sex. The implication was that cells from the bone marrow generated those neurons. However, it is currently thought that neuronal stem cells in mammals, including humans, are self-renewing and therefore do not need to be replenished. Thus, these findings have not been interpreted as contributing to a natural physiological mechanism.

Every experiment we did confirmed the close relationship between the immune system and adult neurogenesis, Beltz said. Often when one is doing research, experiments can be fussy or give variable results. But for this work, once we started asking the right questions, the experiments worked first time and every time. The consistency and strength of the data are remarkable.

Our findings in crayfish indicate that the immune system is intimately tied to mechanisms of adult neurogenesis, suggesting a much closer relationship between the immune system and nervous system than has been previously appreciated, said Sderhll. If further studies demonstrate a similar relationship between the immune system and brain in mammals, these findings would stimulate a new area of research into immune therapies to target neurological diseases.

View post:
Blood Cells Generate Neurons in Crayfish; Could Have Implications for Treatment of Neurodegenerative Disorders

Cedars-Sinai Medical Tip Sheet for August

Contact Information

Available for logged-in reporters only

Newswise Expert on Parkinsons Disease and Depression Available for Interviews Michele Tagliati, M.D., director of the Movement Disorders Program at Cedars-Sinai Medical Center, is available to discuss Parkinsons disease and depression. An internationally renowned expert in all types of movement disorders, including Parkinsons Disease, he believes it is important to understand several aspects of the disease: Parkinsons Disease (PD) is not only a movement disorder; more than half of patients diagnosed with PD also suffer from depression. Many patients say that depression is the most disabling symptom of PD (not shaking or difficulty walking, etc.) Depression is intrinsic to PD, but differs from bipolar or major depression. Its symptoms may include general apathy (loss of interest in life), fatigue, insomnia, lack of appetite, etc. Patients may or may not recognize these as symptomatic of depression, so it is important for their physicians to proactively ask appropriate questions that can help identify depression. While depression can be a major problem for patients with PD, its important to realize that help is available. Medications and counseling can help reduce the severity of symptoms. CONTACT: Sandy Van, 808-526-1708; Email sandy@prpacific.com

Unique Study Focuses on Combined Treatment Approach for Locally Advanced Pancreatic Cancer Investigators at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute are developing a novel, multistep investigational treatment for one of the most complex and difficult-to-treat forms of the disease, locally advanced pancreatic cancer. Locally advanced pancreatic cancer has the lowest survival rate of any solid tumor, with a cumulative five-year survival rate of only 4 percent for all stages of disease. Surgery is rarely an option for patients because tumors often involve vital blood vessels. Chemotherapy and radiotherapy given concurrently remain the mainstay treatment, yet to-date, no treatment has had a significant impact on improving outcomes. CONTACT: Cara Martinez, 310-423-7798; Email cara.martinez@cshs.org

Research Initiative Will Examine Innovative Strategies to Deliver Care More Efficiently Cedars-Sinai has launched an applied research center to improve the value of patient care inside the medical center and beyond its walls by strengthening patient-doctor bonds and bringing greater efficiency to the delivery of clinical services. Brennan Spiegel, MD, MSHS, will lead the new Cedars-Sinai Center for Outcomes Research and Education, or CS-CORE. As director of Health Services Research, he will oversee a digital health strategy aimed at enhancing healthcare quality and reducing excessive use of resources. CONTACT: Duke Helfand, 310-248-6608; Email duke.helfand@cshs.org

Tissue Collection Aids Search for Neurologic and Neuromuscular Disease Causes and Cures Like other major research centers studying genetic causes of uncommon and poorly understood nervous system disorders, Cedars-Sinai maintains a growing collection of DNA and tissue samples donated by patients. What sets Cedars-Sinais Repository of Neurologic and Neuromuscular Disorders apart is its special emphasis on tissue collection part of its focus on creating future individualized treatments for patients. CONTACT: Sandy Van, 808-526-1708; Email sandy@prpacific.com

Congenital Heart Disease Specialists Develop Nonsurgical Technique to Correct Birth Defects in Premature Infants A new technique for repairing the most common cardiac birth defect in newborns, commonly referred to as a hole in the heart, has been used successfully to mend the condition in six premature infants without subjecting the tiny patients to open-heart surgery. The technique for repairing the condition, patent ductus arteriosus, also called PDA, was published online by the peer-reviewed medical journal Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions. CONTACT: Sally Stewart, 310-248-6566; Email sally.stewart@cshs.org

Cedars-Sinai Immunotherapy Expert Honored for Work in Kidney Transplantation Ashley Anh Vo, PharmD, administrative director of the Transplant Immunotherapy Program at the Cedars-Sinai Comprehensive Transplant Center, has been named the 2014 Clinician of Distinction by the American Society of Transplantation for her work in developing anti-rejection drug protocols for patients. CONTACT: Laura Coverson, 310-423-5215; Email laura.coverson@cshs.org

Cedars-Sinai Heart Institute Opens First-of-its-Kind Research Stem Cell Clinic for Cardiac Patients Regenerative medicine experts at the Heart Institute have opened a new clinic to evaluate heart and vascular disease patients for participation in stem cell medical studies. The clinic is believed to be the first at a major U.S. academic medical center dedicated to matching patients with appropriate stem cell clinical trials, whether those research interventions are available at the medical center or at other institutions. CONTACT: Sally Stewart, 310-248-6566; Email sally.stewart@cshs.org

Childbirth Experts Debate Best Delivery Practices at Third Annual Birth Community Day Doctors, nurses, midwives and doulas debated healthy labor and delivery practices including the use of the synthetic hormone Pitocin to hasten childbirth and vitamin K to speed blood clotting in newborns -- at the third annual Cedars-Sinai Birth Community Day. CONTACT: Laura Coverson, 310-423-5215; Email laura.coverson@cshs.org

Originally posted here:
Cedars-Sinai Medical Tip Sheet for August

Adipose-derived stem cells and nerve regeneration

PUBLIC RELEASE DATE:

14-Aug-2014

Contact: Meng Zhao eic@nrren.org 86-138-049-98773 Neural Regeneration Research

Stem cell researchers at the Blond McIndoe Laboratory, University of Manchester, UK, led by Dr Adam Reid, present a review of the current literature on the suitability of adipose-derived stem cells in peripheral nerve repair.

Injuries to peripheral nerves are common and cause life-changing problems for patients alongside high social and health care costs for society. Current clinical treatment relies on sacrificing a nerve from elsewhere in the body to provide a nerve graft at the injury site, but much work has been done to develop a bioengineered nerve graft that would not require this sacrifice. Stem cells are prime candidates as accelerators of regeneration in these nerve grafts.

This prospect, reported in Neural Regeneration Research (Vol. 9, No.14, 2014), presents the current literature on the potential of adipose-derived stem cells as tools to improve nerve regeneration through bioengineered nerve grafts. "Adipose-derived stem cells have the potential to stimulate improved nerve regeneration", stated the authors. "Their incorporation into bioengineered nerve graft treatments could revolutionize the current clinical approach to peripheral nerve repair".

###

Article: "Adipose derived stem cells and peripheral nerve regeneration" by Alessandro Faroni, Richard JP Smith, Adam J Reid (1 Blond McIndoe Laboratories, Institute of Inflammation and Repair, University of Manchester, Manchester, UK; 2 Department of Plastic Surgery & Burns, University Hospital of South Manchester, Manchester, UK)

Faroni A, Smith RJP, Reid AJ. Adipose derived stem cells and peripheral nerve regeneration. Neural Regen Res. 2014;9(14):1341-1346.

Contact: Meng Zhao eic@nrren.org 86-138-049-98773 Neural Regeneration Research http://www.nrronline.org/

Read more here:
Adipose-derived stem cells and nerve regeneration

San Diegan joins state stem cell agency

David Higgins of San Diego, a biotech veteran and an advocate for people with Parkinson's disease, has joined the governing board of California's stem cell agency.

Higgins, who has Parkinson's himself, replaces Joan Samuelson on the Independent Citizens' Oversight Committee that governs the California Institute for Regenerative Medicine. The institute is distributing a total of $3 billion in state bond money in a years-long bid to turn stem cell research into therapies.

Higgins' appointment was announced this week. He was chosen by state Controller John Chiang to take the patient advocate position for Parkinson's disease. Higgins is president of the board for the Parkinson's Association of San Diego.

David Higgins / Parkinson's Association of San Diego

He holds a Ph.D. in molecular biology and genetics from the University of Rochester, and has worked at the biotech companies Invitrogen, Chiron and Idun Pharmaceuticals. Higgins now serves as an adviser to iDiverse, a gene technology company in Del Mar.

In addition, he's a board member for the Center for Ethics in Science and Technology.

And he serves as the San Diego representative for the Parkinson's Action Network, which lobbies elected officials on policies regarding Parkinson's research and treatment.

Higgins is a good choice for the stem cell agency's board not only because of his scientific and medical expertise, but also his personal qualities, said Jerry Henberger, executive director of the local Parkinson's association.

"He's patient, thoughtful, extremely intelligent and a great leader," Henberger said. "We're excited about Parkinson's getting a voice. We know he'll do a great job."

Joe Panetta, a member of the Independent Citizens' Oversight Committee, welcomed Higgins to the board. Panetta is president and chief executive of Biocom, the San Diego-based life science trade group.

Continue reading here:
San Diegan joins state stem cell agency

Transparent Fish Lead to Stem Cell Research Breakthrough

brindafella (702231) writes Australian scientists have accidentally made one of the most significant discoveries in stem cell research, by studying the transparent embryos of Zebrafish (Danio rerio). The fish can be photographed and their development studied over time, and the movies can be played backwards, to track back from key developmental stages to find the stem cell basis for various traits of the fish. This fundamental research started by studying muscles, but the blood stem cell breakthrough was a bonus. They've found out how hematopoietic stem cells (HSC), among the most important stem cells found in blood and bone marrow, is formed. The scientists are based at the Australian Regenerative Medicine Institute at Monash University. The research has been published in the Nature medical journal. This discovery could lead to the production of self-renewing stem cells in the lab to treat multiple blood disorders and diseases.

See more here:
Transparent Fish Lead to Stem Cell Research Breakthrough

Tissue development 'roadmap' created to guide stem cell medicine

15 hours ago

In a boon to stem cell research and regenerative medicine, scientists at Boston Children's Hospital, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston University have created a computer algorithm called CellNet as a "roadmap" for cell and tissue engineering, to ensure that cells engineered in the lab have the same favorable properties as cells in our own bodies. CellNet and its application to stem cell engineering are described in two back-to-back papers in the August 14 issue of the journal Cell.

Scientists around the world are engaged in culturing pluripotent stem cells (capable of forming all the body's tissues) and transforming them into specialized cell types for use in research and regenerative medicine. Available as an Internet resource for any scientist to use, CellNet provides a much needed "quality assurance" measure for this work.

The two papers also clarify uncertainty around which methods are best for stem cell engineering, and should advance the use of cells derived from patient tissues to model disease, test potential drugs and use as treatments. For example, using CellNet, one of the studies unexpectedly found that skin cells can be converted into intestinal cells that were able to reverse colitis in a mouse model.

"To date, there has been no systematic means of assessing the fidelity of cellular engineeringto determine how closely cells made in a petri dish approximate natural tissues in the body," says George Q. Daley, MD, PhD, Director of the Stem Cell Transplantation Program at Boston Children's and senior investigator on both studies. "CellNet was developed to assess the quality of engineered cells and to identify ways to improve their performance."

Gene Signatures

CellNet applies network biology to discover the complex network of genes that are turned on or off in an engineered cell, known as the cell's Gene Regulatory Network or GRN. It then compares that network to the cell's real-life counterpart in the body, as determined from public genome databases. Through this comparison, researchers can rigorously and reliably assess:

"CellNet will also be a powerful tool to advance synthetic biologyto engineer cells for specific medical applications," says James Collins, PhD, Core Faculty member at the Wyss Institute and the William F. Warren Distinguished Professor at Boston University, co-senior investigator on one of the studies.

Putting CellNet to the Test

The researchersincluding co-first authors Patrick Cahan, PhD and Samantha Morris, PhD, of Boston Children's, and Hu Li, PhD, of the Mayo Clinic, first used CellNet to assess the quality of eight kinds of cells created in 56 published studies.

See the rest here:
Tissue development 'roadmap' created to guide stem cell medicine

Trying out a stem cell facial

TO SOME people, the term stem cell may seem kind of taboo. I personally would not want something from animals injected into my system. But Im okay with non-invasive treatments, so I was interested to try out a plant-based stem cell facial.

After cleansing and toning, cotton pads moistened with a clear solution were laid on my eyelids to protect them from a three-minute steaming session. This was followed by a special tool called a scrubber that kind of looks like a computer mouse, but helps to remove dead skin cells and unblock pores without using the rather painful pricking tool.

Next, a rejuvenating gel was applied, followed by the plant-derived stem cell formula. A unique cooling machine was used to massage it into the skin for 10 minutes. Using this machine for cold electrophoresis helps the skin absorb serums and vitamins, without having to use injections. This was great for someone like me, who is wary of invasive treatments. The cooling machine feels like having an ice-cold metal ball massaged on the face; very invigorating, indeed.

Just when I thought my skin already got a lot of pampering, the stem cell was followed by a face mask full of natural vitamins. While it penetrated into my skin, I was given an arm and foot massage, which was nice for further relaxation.

With my combination skin, I looked pretty greasy right afterwards. When I woke up the next day, I didnt see a visible difference in my skin, but it was very smooth and supple to the touch. You may not see instant results with a treatment like this, but its a good treatment to maintain radiance, softness and hydration from beneath the surface of the skin.

This type of facial is not recommended for those with oily or acne-prone skin because the added oiliness may exacerbate problems, but it is ideal for those with dry or mature skin, as it is deeply nourishing and moisturizing. After the first treatment or over time, depending on the condition of your skin, stem cell diminishes fine lines, prevents wrinkles, and promotes cell renewal (a process that slows with age) to give that glowing look that signifies healthy, youthful skin.

I tried out the stem cell facial at Lohas skin and slimming center on Paseo Saturnino, Banilad. Its a more upscale experience here with your own room, as opposed to being in one large room with dividers, in case privacy is an issue for you. All of their machines and products are brought in from Korea and their staff, like my therapist Jennylyn, are highly knowledgeable and know just how much pressure to apply during the treatment. The service, facilities and products used add up to a luxurious treatment session that makes one feel very pampered.

Published in the Sun.Star Cebu newspaper on August 15, 2014.

See original here:
Trying out a stem cell facial

New Blood: Tracing the Beginnings of Hematopoietic Stem Cells

Contact Information

Available for logged-in reporters only

Newswise Hematopoietic stem cells (HSCs) give rise to all other blood cell types, but their development and how their fate is determined has long remained a mystery. In a paper published online this week in Nature, researchers at the University of California, San Diego School of Medicine elaborate upon a crucial signaling pathway and the role of key proteins, which may help clear the way to generate HSCs from human pluripotent precursors, similar to advances with other kinds of tissue stem cells.

Principal investigator David Traver, PhD, professor in the Department of Cellular and Molecular Medicine, and colleagues focused on the Notch signaling pathway, a system found in all animals and known to be critical to the generation of HSCs in vertebrates. Notch signaling between emitting and receiving cells is key to establishing HSC fate during development, said Traver. What has not been known is where, when and how Notch signal transduction is mediated.

Traver and colleagues discovered that the Notch signal is transduced into HSC precursor cells from signal emitting cells in the somite embryologic tissues that eventually contribute to development of major body structures, such as skeleton, muscle and connective tissues much earlier in the process than previously anticipated.

More specifically, they found that JAM proteins, best known for helping maintain tight junctions between endothelial cells to prevent vascular leakage, were key mediators of Notch signaling. When the researchers caused loss of function in JAM proteins in a zebrafish model, Notch signaling and HSCs were also lost. When they enforced Notch signaling through other means, HSC development was rescued.

To date, it has not been possible to generate HSCs de novo from human pluripotent precursors, like induced pluripotent stem cells, said Traver. This has been due in part to a lack of understanding of the complete set of factors that the embryo uses to make HSCs in vivo. It has also likely been due to not knowing in what order each required factor is needed.

Our studies demonstrate that Notch signaling is required much earlier than previously thought. In fact, it may be one of the earliest determinants of HSC fate. This finding strongly suggests that in vitro approaches to instruct HSC fate from induced pluripotent stem cells must focus on the Notch pathway at early time-points in the process. Our findings have also shown that JAM proteins serve as a sort of co-receptor for Notch signaling in that they are required to maintain close contact between signal-emitting and signal-receiving cells to permit strong activation of Notch in the precursors of HSCs.

The findings may have far-reaching implications for eventual development of hematopoietic stem cell-based therapies for diseases like leukemia and congenital blood disorders. Currently, it is not possible to create HSCs from differentiation of embryonic stem cells or induced pluripotent stem cells pluripotent cells artificially derived from non-pluripotent cells, such as skin cells that are being used in other therapeutic research efforts.

Co-authors include Isao Kobayashi, Jingjing Kobayashi-Sun, Albert D. Kim and Claire Pouget, UC San Diego Department of Cellular and Molecular Medicine; Naonobu Fujita, UC San Diego Section of Cell and Developmental Biology; and Toshio Suda, Keio University, Japan.

Read the original post:
New Blood: Tracing the Beginnings of Hematopoietic Stem Cells

Animal-free reprogramming of adult cells improves safety

20 hours ago Growing stem cells in conditions free of animal material makes them safe for use in humans. Credit: Eraxion/iStock/Thinkstock

Human stem cells produced through genetic reprogramming are beset by safety concerns because current techniques alter the DNA of the stem cells and use material from animals to grow them. Now, A*STAR researchers have developed an efficient approach that produces safe, patient-specific human stem cells.

Human induced pluripotent stem cells have the potential to treat a number of diseases without the ethical issues associated with embryonic stem cells. Pluripotent stem cells can be produced from adult cells by introducing genes that reprogram them. Typically, the stem cells are grown on a layer of mouse cells in solutions (known as media) that contain animal proteinsand therefore, potentially may also carry disease. For such stem cells to be safe for use in humans, they need to be grown in 'xeno-free' conditions, which are devoid of material from other animals.

Andrew Wan and Hong Fang Lu at the A*STAR Institute of Bioengineering and Nanotechnology in Singapore and colleagues set out to develop a new xeno-free system. The researchers carried out the genetic reprogramming of cells on an artificially produced protein substrate rather than mouse cells. They also used media that contained no animal components. The result was more efficient reprogramming than seen with conventional approaches.

"A xeno-free system will eliminate the risk of disease transmission from other species, which is important for regulatory approval," explains Wan. "Yet there have been few studies on cell reprogramming under totally xeno-free conditions."

The researchers went one step further by addressing the problem of cells acquiring alterations to their DNA during reprogramming.

"Incorporation of transgenes into the genome of the cell poses another safety issue, risking unwanted genetic alterations," explains Lu. "In our work, the transgenes were introduced to initiate the reprogramming, but after this they were removed from the cell, leading to transgene-free stem cells."

The researchers demonstrated that after genetic reprogramming and the removal of the added genes, the stem cells could still develop into different cells types. They were even able to induce them to form dopaminergic neurons, the type that degenerates in Parkinson's disease. The conditions in which the stem cells were grown mean that they are suitable for clinical use and can be derived from a patient's own cells, ensuring complete compatibility.

"Regulatory approval for clinical application of stem cells largely depends on the conditions in which the stem cells are derived," says Wan. "We present a workable protocol for the reprogramming of fibroblasts to stem cells that minimizes any potential safety risks."

Explore further: Discovery may make it easier to develop life-saving stem cells

Link:
Animal-free reprogramming of adult cells improves safety